American Healthcare REIT, Inc. (AHR) Insider Trading Activity

NYSE$56.19+1.26 (2.29%)
Market Cap
$11.95B
Sector
Real Estate
Industry
REIT—Healthcare Facilities
Rank in Sector
68 of 162
Rank in Industry
7 of 9

AHR Insider Trading Activity

AHR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$5,393,357
9
100

Related Transactions

Foster Mark E.EVP, GC & Secretary
0
$0
5
$481,450
$-481,450
PEAY BRIANChief Financial Officer
0
$0
1
$1.27M
$-1.27M
Hanson Jeffrey Tdirector
0
$0
3
$3.64M
$-3.64M

About American Healthcare REIT, Inc.

American Healthcare REIT (AHR) was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare Investors. This comprehensive merger has established AHR as a leading global real estate investment trust focused on healthcare properties, boasting an impressive portfolio with a gross investment value of approximately $4.2 billion. A core strength of the company lies in its fully integrated …

Insider Activity of American Healthcare REIT, Inc.

Over the last 12 months, insiders at American Healthcare REIT, Inc. have bought $0 and sold $5.39M worth of American Healthcare REIT, Inc. stock.

On average, over the past 5 years, insiders at American Healthcare REIT, Inc. have bought $0 and sold $2.85M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 6,718,919 shares for transaction amount of $0 was made by RECP IV Cite CMBS Equity, L.P. (10 percent owner) on 2010‑03‑17.

List of Insider Buy and Sell Transactions, American Healthcare REIT, Inc.

2026-09-25SaleFoster Mark E.EVP, GC & Secretary
1,500
0.0008%
$52.06
$78,090
+0.83%
2026-09-01SaleFoster Mark E.EVP, GC & Secretary
2,000
0.0009%
$55.39
$110,780
-6.80%
2026-06-26SalePEAY BRIANChief Financial Officer
25,000
0.012%
$50.70
$1.27M
+6.08%
2026-06-24SaleFoster Mark E.EVP, GC & Secretary
2,500
0.0012%
$48.58
$121,450
+7.92%
2026-03-25SaleFoster Mark E.EVP, GC & Secretary
2,000
0.0011%
$48.55
$97,100
+9.20%
2025-12-23SaleHanson Jeffrey Tdirector
19,208
0.0108%
$48.40
$929,690
+7.54%
2025-12-22SaleHanson Jeffrey Tdirector
35,570
0.0201%
$48.38
$1.72M
+7.16%
2025-11-11SaleFoster Mark E.EVP, GC & Secretary
1,500
0.0009%
$49.35
$74,030
+4.28%
2025-11-10SaleHanson Jeffrey Tdirector
20,010
0.0119%
$49.68
$994,105
+3.89%
2025-09-03SaleFoster Mark E.EVP, GC & Secretary
3,850
0.0023%
$41.89
$161,272
+17.91%
2025-06-30SaleOh Stefan K.L.Chief Investment Officer
3,860
0.0024%
$36.10
$139,346
+30.51%
2010-03-17PurchaseRECP IV Cite CMBS Equity, L.P.10 percent owner
6.72M
–
$0
$0
2007-08-17PurchaseFRATER HUGH Rdirector
12,000
0.0024%
$9.16
$109,920
2007-08-16PurchaseFRATER HUGH Rdirector
12,140
0.0021%
$7.88
$95,663
2005-03-15SaleFRATER HUGH Rdirector
1,000
0.0003%
$11.65
$11,650
Total: 15
*Gray background shows transactions not older than one year

AHR Institutional Investors: Active Positions

Increased Positions313+67.75%38M+25.11%
Decreased Positions199-43.07%11M-7.25%
New Positions122New11MNew
Sold Out Positions37Sold Out1MSold Out
Total Postitions576+24.68%179M+17.87%

AHR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$1.11M12.65%23.53M+611,809+2.67%2025-09-30
Blackrock, Inc.$872,702.009.93%18.47M+655,085+3.68%2025-09-30
Principal Financial Group Inc$421,917.004.8%8.93M-857,418-8.76%2025-09-30
Wellington Management Group Llp$409,033.004.66%8.66M-1M-12.72%2025-09-30
State Street Corp$324,872.003.7%6.88M-25,897-0.38%2025-09-30
Invesco Ltd.$252,949.002.88%5.35M-465,981-8.01%2025-09-30
Geode Capital Management, Llc$230,146.002.62%4.87M+292,970+6.4%2025-09-30
Alliancebernstein L.P.$229,560.002.61%4.86M-459,433-8.64%2025-09-30
Prudential Financial Inc$192,212.002.19%4.07M+1M+48.9%2025-09-30
Fmr Llc$167,914.001.91%3.55M+705,347+24.76%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.